The development of anti-CD79 monoclonal antibodies for treatment of B- cell neoplastic disease

Therapeutic Immunology

Volumn 2, Issue 4, 1995, Pages 191-202

  Zhang, L ^a   French, R R ^a   Chan, H T C ^a   O'Keefe, T L ^a   Cragg, M S ^a   Power, M J D ^a   Glennie, M J ^a  

^a Chest Department   (United Kingdom)

Author keywords

B cell receptor complex; CD79; Immunotherapy; Lymphoma; Monoclonal antibody; Surface IgM

Indexed keywords

CD79 ANTIGEN; IMMUNOGLOBULIN M; IODINE 125; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; B CELL LYMPHOMA; BINDING KINETICS; BURKITT LYMPHOMA; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, CD; ANTIGENS, CD79; BURKITT LYMPHOMA; CELL DIVISION; CHO CELLS; CRICETINAE; HUMANS; MICE; PRECIPITIN TESTS; RECEPTORS, ANTIGEN, B-CELL; TUMOR CELLS, CULTURED;

EID: 0029430487     PISSN: 09670149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)